SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW
3,405.00
+10.00 (0.29%)
At close: Apr 17, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| | 123.41M | 243.99M | 316.66M | 609.68M |
Medical Labs & Research Growth | | -49.42% | -22.95% | -48.06% | - |
| | 123.41M | 243.99M | 316.66M | 609.68M |
| | -49.42% | -22.95% | -48.06% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| | 123.41M | 243.99M | 316.66M | 609.68M |
| | -49.42% | -22.95% | -48.06% | - |
| | 123.41M | 243.99M | 316.66M | 609.68M |
| | -49.42% | -22.95% | -48.06% | - |
Source: S&P Global Market Intelligence.
